Emapalumab in Primary Hemophagocytic Lymphohistiocytosis. Reply

N Engl J Med. 2020 Aug 6;383(6):598-599. doi: 10.1056/NEJMc2020754.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal
  • Antibodies, Neutralizing
  • Humans
  • Immunosuppressive Agents
  • Lymphohistiocytosis, Hemophagocytic*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Neutralizing
  • Emapalumab
  • Immunosuppressive Agents